Breckenridge Signs Agreement With German Drugmaker

January 20, 2009
Florida-based Breckenridge Pharmaceutical has entered into an agreement with German drugmaker Helm to develop an asthma product — the third deal the companies have concluded over the past year. Under terms of this new agreement, Breckenridge will submit an ANDA to the FDA this year for the product Helm is developing.
Generic Line